Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

13.43

-0.31 (-2.26%)

Aug 6, 2025, 3:51 PM - Market open

Accolade Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Aug '25 Aug 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	1,413	2,528	694	565	753	-	Upgrade
Market Cap Growth	23.33%	264.15%	22.85%	-24.97%	-	-	Upgrade
Enterprise Value	937	2,040	410	203	463	-	Upgrade
Last Close Price	13.74	26.70	10.94	8.94	15.28	-	Upgrade
PB Ratio	3.04	5.51	2.18	1.63	2.75	-	Upgrade
P/TBV Ratio	3.19	5.51	2.18	1.63	2.75	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.02	0.01	-	-	Upgrade
Quick Ratio	20.67	19.70	18.99	21.22	26.69	29.73	Upgrade
Current Ratio	20.99	19.93	19.50	21.53	26.97	29.86	Upgrade
Return on Equity (ROE)	-30.29%	-34.40%	-30.10%	-21.78%	-21.34%	-22.80%	Upgrade
Return on Assets (ROA)	-21.08%	-24.01%	-20.21%	-13.73%	-12.97%	-13.80%	Upgrade
Return on Capital (ROIC)	-21.81%	-25.19%	-21.17%	-14.32%	-13.46%	-14.31%	Upgrade
Earnings Yield	-10.67%	-5.29%	-14.43%	-11.97%	-5.68%	-	Upgrade
FCF Yield	-8.72%	-4.36%	-14.07%	-10.29%	-4.54%	-	Upgrade
Buyback Yield / Dilution	-35.11%	-45.02%	-18.90%	-42.82%	-4977.96%	-95.63%	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q